Leprosy exposure, infection and disease: A 25-year surveillance study of leprosy patient contacts

Memorias do Instituto Oswaldo Cruz

Volumn 107, Issue 8, 2012, Pages 1054-1059

  Sarno, Euzenir Nunes ^a   Duppre, Nadia Cristina ^a   Sales, Anna Maria ^a   Hacker, Mariana Andréa ^a   Nery, José Augusto ^a   de Matos, Haroldo José ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b INSTITUTO EVANDRO CHAGAS   (Brazil)

Author keywords

Contact surveillance; Epidemiology; Leprosy; PGL 1

Indexed keywords

ARTICLE; BIOLOGICAL MODEL; COHORT ANALYSIS; CONTACT EXAMINATION; DISEASE TRANSMISSION; FAMILY SIZE; HEALTH SURVEY; HUMAN; INCIDENCE; LEPROSY; STATISTICS; TIME;

COHORT STUDIES; CONTACT TRACING; FAMILY CHARACTERISTICS; HUMANS; INCIDENCE; LEPROSY; MODELS, BIOLOGICAL; POPULATION SURVEILLANCE; TIME FACTORS;

EID: 84871756174     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762012000800015     Document Type: Article

References (34)

1. Abel L, Demenais F 1988. Detection of major genes for susceptibility to leprosy and its subtypes. Genet 42: 256-266.
2. Alvim MFS 1993. Efeito protetor do BCG na hanseníase. Um estudo caso-controle, MsD Thesis, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, 140 pp.
3. Barreto JG, Guimarães LS, Leão MRN, Ferreira DVG, Lima RAA, Salgado CG 2011. Anti-PGL-1 seroepidemiology in leprosy cases: household contacts and school children from a hyperendemic municipality of the Brazilian Amazon. Lep Rev 82: 358-370.
4. Bobosha K, van Schip JJC, Esquenazi DA, Guimarães MM, Martins MV, Bekele Y, Fantahun Y, Aseffa A, Franken KLMC, Gismondi RC, Pessolani MCV, Ottenhoff THM, Pereira GMB, Geluk A 2012. Peptides derived from Mycobacterium leprae ML1601c. Discriminate between leprosy patients and healthy endemic controls. J Trop Med 2012: 132049.
5. Chanteau S, Glaziou P, Plichart C, Luquiaud P, Plichart R, Faucher JF, Cartel JL 1993. Low predictive value of PGL-I serology for the early diagnosis of leprosy in family contacts: results of a 10year prospective field study in French Polynesia. Int J Lepr Other Mycobact Dis 61: 533-541.
6. Duppre NC, Camacho LA, da Cunha SS, Struchiner CJ, Sales AM, Nery JAC, Sarno EN 2008. Effectiveness of BCG vaccination among leprosy contacts: a cohort study. Trans R Soc Trop Med Hyg 102: 631-638.
7. Duppre NC 2008. Risco de desenvolver hanseníase em contatos de pacientes, segundo positividade ao teste anti-PGL-I e situação vacinal (BCG), PhD Thesis, Fundação Oswaldo Cruz, Rio de Janeiro, 229 pp.
8. Feenstra SG, Nahar Q, Pahan D, Richardus JH 2012. Social contact patterns and leprosy disease: a case-control study in Bangladesh. Epidemiol Infect 14: 1-9.
9. Feitosa MF, Borecki I, Krieger H, Beiguelman B, Rao DC 1995. The genetic epidemiology of leprosy in a Brazilian population. Am J Hum Genet 6: 1179-1185.
10. Fischer EAJ, de Vlas SJ, Habbema JDF, Richardus JH 2011. The long term effect of current and new interventions on the new case detection of leprosy: a modeling study. PLoS Negl Trop Dis 5: e1330.
11. Fine PEM 1988. BCG vaccination against tuberculosis and leprosy. British Medical Bulletin 44: 691-703.
12. Fine PEM 1982. Leprosy: the epidemiology of a slow bacterium. Epidemiol Rev 4: 161-168.
13. Fine PEM, Sterne JAC, Pönnighaus JM, Bliss L, Saul J, Chihana A, Munthali M, Warndorff DK 1997. Household and dwelling contact as risk factors for leprosy in northern Malawi. Am J Epid 146: 91-102.
14. Fine PEM, Sterne JAC, Pönnighaus JM, Rees RJW 1994. Delayedtype hypersensitivity, mycobacterial vaccines and protective immunity. The Lancet 344: 1245-1249.
15. Fischer E, de Vlas S, Meima A, Habbema D, Richardus J 2010. Different mechanisms for heterogeneity in leprosy susceptibility can explain disease clustering within households. PLoS ONE 5: e14061.
16. Goulart IMB, Souza DOB, Marques CR, Pimenta, VL, Gonçalves MA, Goulart LR 2008. Risk and protective factors for leprosy development determined by epidemiological surveillance of household contacts. Clin Vac Immunol 15: 101-105.
17. Lazaro FP, Werneck RI, Mackert CCO, Cobat A, Prevedello C, Pimentel RP, Macedo GMM, Eleutério AM, Vilar G, Abel L, Xavier MB, Alcais A, Mira MT 2010. A major gene controls leprosy susceptibility in a hyperendemic isolated population from North of Brazil. J Infec Diseases 201: 1598-1605.
18. Matos HJ, Duppre N, Alvim MF, Machado-Vieira LM, Sarno EN, Struchiner CJ 1999. Leprosy epidemiology in a cohort of household contacts in Rio de Janeiro (1987-1991). Cad Saude Publica 15: 533-542.
19. Moet FJ, Pahan D, Schuring RP, Oskam L, Richardus JH 2006. Physical distance, genetic relationship, age and leprosy classification are independent risk factors for leprosy in contacts of patients with leprosy. J Infect Dis 193: 346.
20. Moura RS, Calado KL, Oliveira MLW, Bührer-Sékula S 2008. Sorologia da hanseníase utilizando PGL-1: revisão sistemática. Rev Soc Bra Med Trop 41 (Suppl. II): 11-18.
21. Neeloo S, Agrawal S, Rastogi AK 1997. Infectious disease and immunity: special reference to major histocompatibility complex. Emerg Infect Dis 3: 41-49.
22. Noordeen SK 1993. Leprosy 1962-1992. Epidemiology and control of leprosy a review of progress over the last 30 years. Trans R Soc Trop Med Hyg 87: 515-517.
23. Ranade MG, Joshi GY 1995. Long-term follow-up of families in an endemic area. Indian J Lepr 67: 411-425.
24. Richardus JH, Habbema JD 2007. The impact of leprosy control on the transmission of M. leprae: is elimination being attained? Lepr Rev 78: 330-337.
25. Ridley DS, Jopling WH 1962. A classification of leprosy for research purposes. Lepr Rev 33: 119-128.
26. Ridley DS, Jopling WH 1966. Classification of leprosy according to immunity. Int J Lepr Other Mycobact Dis 34: 255-273.
27. Rodriguez G, Orozco LC 1996. Lepra, Instituto Nacional de Salud, Santafé de Bogotá, 220 pp.
28. Saad MHF, Medeiros MA, Gallo MEN, Gontijo PP, Fonseca LS 1990. IgM immunoglobulins reacting with the phenolic glycolipid-1 antigen from Mycobacterium leprae in sera of leprosy patients and their contacts. Mem Inst Oswaldo Cruz 85: 191-194.
29. Sales AM, Ponce de Leon A, Duppre NC, Hacker MA, Nery JAC 2011. Leprosy among patient contacts: a multilevel study of risk factors. PLoS Negl Trop Dis 5: e1013.
30. Sampaio EP, Moreira AL, Kaplan G, Alvim MFS, Duppre NC, Miranda CF, Sarno EN 1991. Mycobacterium leprae-induced interferon-γ production by household contacts of leprosy patients: association with development of active disease. J Infec Dis 164: 990-993.
31. Shen JP, Zhang GC, Chen XS, Zhou M, Yu MW, Yan LB 2008. A long-term evolution on the epidemiological characteristics of leprosy, towards the goal of its elimination in 1949-2007 in China. Chin J Epidemiol 29: 1095-1100.
32. van Beers SM, Izumi S, Madjid B, Maeda Y, Day R, Klaster PR 1994. An epidemiological study of leprosy infection by serology and polymerase chain reaction. Int J Lepr Other Mycobact Dis 62: 1-9.
33. Vanderborght PR, Matos HJ, Salles AM, Vasconcellos SE, Silva-Filho VF, Huizinga TW, Ottenhoff TH, Sampaio EP, Sarno EN, Santos AR, Moraes MO 2004. Single nucleotide polymorphisms (SNPs) at -238 and -308 positions in the TNF-alpha promoter: clinical and bacteriological evaluation in leprosy. Int J Lepr Other Mycobact Dis 72: 143-148.
34. WHO World Health Organization 1998. Elimination of leprosy as a public health problem (update). Weekly Epidemiol Rec 73: 169-176.